SK287896B6 - Process for preparing 7-hydroxy-3,4-dihydrocarbostyril - Google Patents
Process for preparing 7-hydroxy-3,4-dihydrocarbostyril Download PDFInfo
- Publication number
- SK287896B6 SK287896B6 SK5037-2006A SK50372006A SK287896B6 SK 287896 B6 SK287896 B6 SK 287896B6 SK 50372006 A SK50372006 A SK 50372006A SK 287896 B6 SK287896 B6 SK 287896B6
- Authority
- SK
- Slovakia
- Prior art keywords
- dihydrocarbostyril
- hydroxy
- formula
- hydrogenation
- impurity
- Prior art date
Links
- LKLSFDWYIBUGNT-UHFFFAOYSA-N 7-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=CC(O)=CC=C21 LKLSFDWYIBUGNT-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title abstract description 5
- DBSPUDKBNOZFMX-UHFFFAOYSA-N 7-hydroxyquinolin-2(1H)-one Chemical compound C1=CC(=O)NC2=CC(O)=CC=C21 DBSPUDKBNOZFMX-UHFFFAOYSA-N 0.000 claims abstract description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 239000012535 impurity Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 238000005984 hydrogenation reaction Methods 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- PNLKLWHMPQKCEV-UHFFFAOYSA-N 3-chloro-n-(3-hydroxyphenyl)propanamide Chemical compound OC1=CC=CC(NC(=O)CCCl)=C1 PNLKLWHMPQKCEV-UHFFFAOYSA-N 0.000 claims description 7
- 239000003054 catalyst Substances 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 229910052763 palladium Inorganic materials 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 claims description 3
- 229940018563 3-aminophenol Drugs 0.000 claims description 3
- INUNLMUAPJVRME-UHFFFAOYSA-N 3-chloropropanoyl chloride Chemical compound ClCCC(Cl)=O INUNLMUAPJVRME-UHFFFAOYSA-N 0.000 claims description 3
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminum chloride Substances Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 238000001953 recrystallisation Methods 0.000 claims 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 abstract description 2
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 description 12
- 230000009467 reduction Effects 0.000 description 9
- 229960004372 aripiprazole Drugs 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000033444 hydroxylation Effects 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- POTIYWUALSJREP-UHFFFAOYSA-N 1,2,3,4,4a,5,6,7,8,8a-decahydroquinoline Chemical compound N1CCCC2CCCCC21 POTIYWUALSJREP-UHFFFAOYSA-N 0.000 description 1
- TZOYXRMEFDYWDQ-UHFFFAOYSA-N 3,4-dihydro-1h-quinolin-2-one Chemical compound C1=CC=C2NC(=O)CCC2=C1 TZOYXRMEFDYWDQ-UHFFFAOYSA-N 0.000 description 1
- 229910000497 Amalgam Inorganic materials 0.000 description 1
- 102000007527 Autoreceptors Human genes 0.000 description 1
- 108010071131 Autoreceptors Proteins 0.000 description 1
- 229910014265 BrCl Inorganic materials 0.000 description 1
- -1 C 4 alcohols Chemical class 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 238000006085 Schmidt reaction Methods 0.000 description 1
- 239000000164 antipsychotic agent Substances 0.000 description 1
- 229940005529 antipsychotics Drugs 0.000 description 1
- CODNYICXDISAEA-UHFFFAOYSA-N bromine monochloride Chemical group BrCl CODNYICXDISAEA-UHFFFAOYSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000003997 cyclic ketones Chemical class 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000000442 dopamine 2 receptor blocking agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 239000004031 partial agonist Substances 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 230000001242 postsynaptic effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003518 presynaptic effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ20050338A CZ300351B6 (cs) | 2005-05-26 | 2005-05-26 | Zpusob prípravy 7-hydroxy-3,4-dihydrokarbostyrilu |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK50372006A3 SK50372006A3 (sk) | 2006-12-07 |
| SK287896B6 true SK287896B6 (sk) | 2012-03-02 |
Family
ID=37482386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK5037-2006A SK287896B6 (sk) | 2005-05-26 | 2006-04-07 | Process for preparing 7-hydroxy-3,4-dihydrocarbostyril |
Country Status (2)
| Country | Link |
|---|---|
| CZ (1) | CZ300351B6 (cs) |
| SK (1) | SK287896B6 (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104356063A (zh) * | 2014-10-16 | 2015-02-18 | 华东师范大学 | 7-羟基-3,4-二氢-2-(1h)喹诺酮的制备方法 |
| CN109776408B (zh) * | 2017-11-14 | 2022-12-20 | 上海医药工业研究院 | 一种7-羟基-2-喹啉酮的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS517672B2 (cs) * | 1972-04-13 | 1976-03-10 | ||
| US5006528A (en) * | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| JPH07247271A (ja) * | 1994-01-21 | 1995-09-26 | Otsuka Pharmaceut Co Ltd | ３，４−ジヒドロカルボスチリル誘導体 |
| JP4232211B2 (ja) * | 1998-03-19 | 2009-03-04 | エア・ウォーター株式会社 | ３，４−ジヒドロカルボスチリル類の製造方法 |
-
2005
- 2005-05-26 CZ CZ20050338A patent/CZ300351B6/cs not_active IP Right Cessation
-
2006
- 2006-04-07 SK SK5037-2006A patent/SK287896B6/sk not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ2005338A3 (cs) | 2007-01-17 |
| CZ300351B6 (cs) | 2009-04-29 |
| SK50372006A3 (sk) | 2006-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3733650B1 (en) | Method for preparing elagolix intermediate and composition thereof | |
| CN104844585B (zh) | 一种制备依匹哌唑的方法 | |
| CA2707334C (en) | A process for the preparation or purification of olmesartan medoxomil | |
| US7902377B2 (en) | Method for preparing medetomidine and its salts | |
| CN101006090A (zh) | 4[[(7r)－8－环戊基－7－乙基－5,6,7,8－四氢－5－甲基－4－6－氧代－2－哌啶基]氨基]－3－甲氧基－n－(1－甲基－4－哌啶基)－苯甲酰胺的水合物及多晶型物，其制造方法及其作为药物的用途 | |
| EP1480953B2 (en) | Process for preparing aripiprazole | |
| EP3022209A1 (en) | Dolutegravir salts | |
| EP1873151B1 (en) | Improved process for producing moxonidine | |
| SK287896B6 (sk) | Process for preparing 7-hydroxy-3,4-dihydrocarbostyril | |
| JP4478140B2 (ja) | 医薬用カルボスチリル化合物の製法 | |
| WO2007118923A1 (en) | A process for the preparation of aripiprazole and intermediates thereof | |
| US20100130744A1 (en) | Process for the preparation of aripiprazole | |
| WO2023082839A1 (zh) | 一种Filgotinib的制备方法 | |
| JPH07247271A (ja) | ３，４−ジヒドロカルボスチリル誘導体 | |
| CN111100042B (zh) | 一种2-甲氧基-5-磺酰胺基苯甲酸的制备方法 | |
| WO2013020672A1 (en) | Process for the preparation of aripiprazole | |
| CN1603324A (zh) | 左旋卤代斯库利啉盐及其制备方法和用途 | |
| EP2160384B1 (en) | Process for the preparation of valsartan | |
| CN110183446A (zh) | 一种莫西沙星新杂质及其合成方法和用途 | |
| CN108069900B (zh) | 阿立哌唑盐酸盐的制备方法和用途 | |
| JP6023770B2 (ja) | アリピプラゾール無水物ｂ形結晶の製造方法 | |
| CN111978264B (zh) | 一种地拉罗司的工业化生产方法 | |
| CN116199637A (zh) | 一种地拉罗司的制备方法 | |
| EP2691387B1 (en) | Process for the preparation of anhydrous aripiprazole crystal form ii | |
| JP2006056832A (ja) | ４−ヒドロキシキノリン類の製造方法及び精製方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TC4A | Change of owner's name |
Owner name: ZENTIVA, K.S., PRAHA, DOLNI MECHOLUPY, CZ Effective date: 20120524 |
|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20190407 |